Drug-delivery FDA Cleared Vascular

United Therapeutics and DEKA Announce Additional FDA Clearance Related to the Unity Subcutaneous Delivery System for Remodulin®

Released on February 24, 2020

Remunity™ expected to be available for patients by July 2020 RESEARCH TRIANGLE PARK, N.C. and MANCHESTER, N.H., Feb. 24, 2020 /PRNewswire/ — United Therapeutics Corporation […]

Read more
Digital Health Drug-delivery Wearables

Insulet’s Omnipod to integrate with Dexcom, Abbott CGMs for automated, smartphone-controlled dosing

Released on February 20, 2020

Insulin pump maker Insulin announced partnerships yesterday with two of the leading continuous glucose monitor companies, Abbott and Dexcom. Both involve […]

Read more
Drug-delivery M&A MedTech

Integer expands to Israel

Released on February 19, 2020

Integer Holdings (NYSE:ITGR) today announced it has acquired medtech manufacturer Inomec, formally establishing its presence in Israel. The Plano, Texas-based company […]

Read more
Digital Health Drug-delivery Wearables

Abbott, Dexcom announce plans for CGM compatibility with Insulet system

Released on February 19, 2020

Dive Brief: Continuous glucose monitor market giants Dexcom and Abbott on Wednesday independently announced plans to integrate their newest technologies with […]

Read more
Cardiology CE Mark Drug-delivery

BIOTRONIK’s Orsiro Mission Drug-Eluting Stent

Released on February 12, 2020

BIOTRONIK won the European CE Mark for its Orsiro Mission drug-eluting stent. The device is intended for widening coronary arteries at […]

Read more
Drug-delivery Sensors

Senseonics, Companion Medical to integrate sensor glucose and insulin data

Released on February 11, 2020

Senseonics (NYSE:SENS) will integrate its Eversense continuous glucose monitoring (CGM) system’s real-time glucose data with Companion Medical‘s InPen smart insulin delivery system. The agreement […]

Read more
CE Mark Drug-delivery FDA

Paclitaxel Controversy Is Causing CE Mark Delays for New Paclitaxel Devices

Released on February 6, 2020

Tension over stents and balloons that are either coated with or are designed to release paclitaxel has eased up in the United […]

Read more
Drug-delivery Wearables

Patch Automatically Delivers Insulin as Blood Glucose Rises

Released on February 5, 2020

New technology has been making an impact on how diabetics control their blood sugar levels. A combination of a wearable glucometer […]

Read more
Drug-delivery FDA Approved Women's Health

Contura wins FDA premarket approval for hydrogel injection

Released on February 5, 2020

Contura announced that it won FDA premarket approval for its Bulkamid hydrogel injection for treating stress urinary incontinence (SUI). Bulkamid is Contura’s […]

Read more
Drug-delivery Public Offering

Rani Therapeutics could go the IPO route

Released on January 30, 2020

Rani Therapeutics is reportedly moving forward with an early-stage efficacy and safety study for its robotic pills and may be on […]

Read more
Drug-delivery Vascular

Study: High- and low-dose drug-coated balloons equally effective in PAD

Released on January 30, 2020

A Boston Scientific (NYSE:BSX) device coated with less of the controversial drug paclitaxel than one made by Medtronic (NYSE:MDT) is just […]

Read more
Drug-delivery Funding Vascular

Vascular Therapies closes $17.3m financing

Released on January 29, 2020

Vascular Therapies announced that it closed an upsized private funding round worth more than $17 million with contributions from new and existing […]

Read more